Information exchange method, user end, and system for online collaborative shopping
US-9211239-B2 · Dec 15, 2015 · US
US10154953B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10154953-B2 |
| Application number | US-201615566745-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 18, 2016 |
| Priority date | Apr 28, 2015 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the use of a composition comprising a peroxidic compound and a particular, generically defined copolymer for tooth bleaching.
Opening claim text (preview).
The invention claimed is: 1. A method of bleaching teeth comprising contacting the teeth with a composition comprising a peroxidic compound selected from the group consisting of an organic peroxide compound and hydrogen peroxide, and a copolymer comprising repeat units derived from at least one first monomer which is selected from the group consisting of N-vinylpyrrolidone (N-vinyl-2-pyrrolidone), N-vinyl-2-piperidone, N-vinyl-3-methylpyrrolidinone, N-vinyl-3-methylpiperidone, N-vinyl-3-methylcaprolactam, N-vinyl-4-methylpyrrolidinone, N-vinyl-4-methyl-2-pyrrolidone, N-vinyl-4-methylpiperidone, N-vinyl-4-methylcaprolactam, N-vinyl-5-methylpyrrolidinone, N-vinyl-5-ethyl-2-pyrrolidone, N-vinyl-4-methylpiperidone, N-vinyl-3-ethylpyrrolidinone, N-vinyl-4,5-dimethylpyrrolidinone, N-vinyl-5,5-dimethylpyrrolidinone, N-vinyl-3,3,5-trimethylpyrrolidinone, N-vinyl-5-methyl-5-ethylpyrrolidinone, N-vinyl-3,4,5-trimethyl-3-ethylpyrrolidinone, N-vinyl-6-methyl-2-piperidone, N-vinyl-6-ethyl-2-piperidone, N-vinyl-3,5-dimethyl-2-piperidone, N-vinyl-4,4-dimethyl-2-piperidone, N-vinyl-2-caprolactam, N-vinyl-7-methylcaprolactam, N-vinyl-7-ethylcaprolactam, N-vinyl-3,5-dimethylcaprolactam, N-vinyl-4,6-dimethylcaprolactam, N-vinyl-3,5,7-trimethylcaprolactam, N-vinyl-2-valerolactam, N-vinylhexahydro-2-azepinone, N-vinyloctahydro-2-azocinone, N-vinyloctahydro-2-azoninone, N-vinyldecahydro-2-azecinone, and combinations of these monomers, at least one comonomer which is selected from the group consisting of a monomer comprising at least one phosphoric ester group, a monomer comprising at least one phosphonic acid group, a monomer comprising at least one sulfonic acid group, an ethylenically unsaturated dicarboxylic acid, an ethylenically unsaturated dicarboxylic anhydride, and combinations of these monomers, optionally at least one further free-radically polymerizable, ethylenically unsaturated monomer, and optionally at least one crosslinking comonomer having at least two free-radically polymerizable, ethylenically unsaturated groups in the molecule. 2. The method according to claim 1 , wherein the at least one first monomer is N-vinylpyrrolidone. 3. The method according to claim 1 , wherein the at least one first monomer is N-vinyl-2-caprolactam. 4. The method according to claim 1 , wherein the at least one comonomer is selected from the group consisting of maleic acid, maleic anhydride, fumaric acid, vinylphosphonic acid, 2-acrylamido-2-methylpropanesulfonic acid, acrylamidopropanesulfonic acid, and combinations of these monomers. 5. The method according to claim 1 , wherein the at least one comonomer is selected from the group consisting of vinylphosphonic acid, 2-acrylamido-2-methylpropanesulfonic acid, and combinations of these monomers. 6. The method according to claim 1 , wherein the at least one crosslinking comonomer is selected from the group consisting of N,N′-divinylethyleneurea, N,N′-divinylpropyleneurea, N,N′-divinylimidazolid-2-one, N-vinyl-2-ethylidenepyrrolidone, N-vinyl-3-ethylidenepyrrolidone, methylenebisacrylamide, an allyl ether, a vinyl ether, a (meth)acrylic ester, a (meth)acrylamide of an alcohol or of an amine having more than two functional groups, and combinations of these monomers. 7. The method according to claim 1 , wherein the copolymer comprises, based on the total mass of the repeat units in the copolymer, 70%-99.5% by weight of repeat units derived from the at least one first monomer, 0.5%-30% by weight of repeat units derived from the at least one comonomer, 0% to 20% by weight of repeat units derived from the at least one further free-radically polymerizable, ethylenically unsaturated monomer, 0%-10% by weight of repeat units derived from the at least one crosslinking comonomer, where the sum total of the proportions by weight of the repeat units derived from the at least one first monomer and from the at least one comonomer and from the at least one further free-radically polymerizable, ethylenically unsaturated monomer and from the at least one crosslinking comonomer is 100% by weight. 8. The method according to claim 1 , wherein the at least one first monomer is N-vinylpyrrolidone, and wherein the at least one comonomer is selected from the group consisting of vinylphosphonic acid, 2-acrylamido-2-methylpropanesulfonic acid, and combinations of these monomers, and wherein the copolymer comprises, based on the total mass of the repeat units in the copolymer, 70%-99.5% by weight of repeat units derived from N-vinylpyrrolidone, and 0.5%-30% by weight of repeat units derived from the at least one comonomer, where the sum total of the proportions by weight of the repeat units derived from the at least one first monomer and from the at least one comonomer is 100% by weight. 9. The method according to claim 1 , wherein the at least one first monomer is N-vinyl-2-caprolactam, and wherein the at least one comonomer is selected from the group consisting of vinylphosphonic acid, 2-acrylamido-2-methylpropanesulfonic acid, and combinations of these monomers, and wherein the copolymer comprises, based on the total mass of the repeat units in the copolymer, 70%-99.5% by weight of repeat units derived from N-vinylpyrrolidone, and 0.5%-30% by weight of repeat units derived from the at least one comonomer, where the sum total of the proportions by weight of the repeat units derived from the at least one first monomer and from the at least one comonomer is 100% by weight. 10. The method according to claim 1 , wherein the peroxidic compound is selected from the group consisting of an organic hydroperoxide and hydrogen peroxide. 11. The method according to claim 1 , wherein the composition is present in a formulation selected from the group consisting of a toothpaste, a mouthwash, a gel for tooth bleaching, and an oral spray. 12. The method according to claim 11 , wherein the formulation comprises further known auxiliaries and ingredients for these formulations. 13. The method according to claim 10 , wherein the peroxidic compound is selected from the group consisting of tert-butyl hydroperoxide, cumene hydroperoxide, and hydrogen peroxide. 14. The method of claim 1 wherein the peroxide compound is hydrogen peroxide.
Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers · CPC title
by a heterocyclic ring containing nitrogen · CPC title
N-Vinyl-pyrrolidone · CPC title
Peroxides; Oxygen; Ozone · CPC title
Preparations for deodorising, bleaching or disinfecting dentures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.